By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cerus Corporation 

2411 Stanwell Drive

Concord  California  94520   U.S.A.
Phone: 925-288-6000 Fax: 925-288-6001


Medical Device



Company News
Cerus (CERS) And Unyts Enter Into Agreement For The Use Of INTERCEPT Platelets And Plasma 7/21/2015 8:04:26 AM
Cerus (CERS) And Bonfils Blood Center Enter Into Agreement For The Use Of INTERCEPT Platelets And Plasma 7/13/2015 10:08:53 AM
Cerus (CERS) To Release Second Quarter 2015 Results On August 6, 2015 7/6/2015 8:56:48 AM
Cerus (CERS) To Present At Cantor Fitzgerald’s Inaugural Healthcare Conference On July 8, 2015 7/1/2015 11:26:26 AM
Cerus (CERS) Release: First INTERCEPT Pathogen Reduced Platelet Units Produced In The Continental US 6/29/2015 1:33:01 PM
Cerus (CERS) Brings in a New Chief Medical Officer 6/8/2015 7:16:42 AM
Cerus Corporation (CERS) Reports First Quarter 2015 Results 5/6/2015 11:46:37 AM
Cerus Corporation (CERS) To Present At AABB Symposium On Pathogen-Reduced Components 4/27/2015 11:34:25 AM
Cerus Corporation (CERS) To Release First Quarter 2015 Results On May 5, 2015 4/22/2015 8:36:21 AM
First Patient Enrolled In Cerus Corporation (CERS)' TRUE Study With The American Red Cross To Address Chikungunya And Dengue Blood Safety Risks With Pathogen Reduced Platelets 3/16/2015 9:48:44 AM